Risperidone versus Conventional Antipsychotics for Schizophrenia and???Schizoaffective Disorder

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

1992 • 33,264 citations

The MOS 36-ltem Short-Form Health Survey (SF-36)

1992 • 26,794 citations

Foundations of Behavioral Research

1974 • 7,648 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

A Rating Scale for Drug-Induced Akathisia

1989 • 2,135 citations

Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study.

1995 • 1,728 citations

Kaplan & Sadock's Comprehensive Textbook of Psychiatry

2000 • 1,469 citations

Unbalanced Repeated-Measures Models with Structured Covariance Matrices

1986 • 1,343 citations

A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

2003 • 1,008 citations

Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations

1998 • 937 citations

The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis

1997 • 705 citations

Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies

2004 • 691 citations

Patterns of Usual Care for Schizophrenia: Initial Results From the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey

1998 • 628 citations

Chronic mental patients: the quality of life issue

1982 • 478 citations

What Information Do Consumers Want and How Will They Use It?

1995 • 399 citations

Phenothiazine Treatment in Acute Schizophrenia

1964 • 321 citations

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.

1964 • 303 citations

Measuring Quality of Life in Patients with Schizophrenia

1997 • 195 citations

Relapse and Rehospitalisation Rates in Patients with Schizophrenia

2002 • 182 citations

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

1999 • 139 citations

The Positive-Negative Distinction in Drug-Free Schizophrenic Patients

1989 • 135 citations

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study

2002 • 103 citations

Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders

2002 • 50 citations

Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia

1999 • 48 citations

Rehospitalization risk with second-generation and depot antipsychotics.

2003 • 47 citations

Clinical research techniques in tardive dyskinesia

1977 • 47 citations

Rehospitalization Risk with Second-Generation and Depot Antipsychotics

2003 • 44 citations

Benzodiazepines in Schizophrenia

1996 • 42 citations

The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice.

1999 • 29 citations

Impact of newer antipsychotics on outcomes in schizophrenia

1997 • 25 citations

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study

2002 • 20 citations